MA07.02 Updated Efficacy and Safety Data from the Phase 2 NP28761 Study of Alectinib in ALK-Positive Non-Small-Cell Lung Cancer
暂无分享,去创建一个
M. Socinski | A. Shaw | S. Ou | Gregory Riely | H. Borghaei | D. Camidge | T. Mekhail | S. Gadgeel | L. Gandhi | K. Gold | J. Cetnar | A. Chiappori | B. Chao | H. West | B. Balas | A. Zeaiter | W. Bordogna | J. Noé | S. Golding